Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tablet tool aims to boost pregnancy care in south asia

NCT ID NCT03700034

Knowledge-focused Sponsor: Public Health Foundation of India Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a tablet-based decision support system helps frontline health workers in India and Nepal provide better antenatal care. About 1,320 pregnant women will take part. The tool guides workers to check blood pressure, blood sugar, urine protein, and hemoglobin, aiming to catch and manage conditions like gestational diabetes, pregnancy-induced hypertension, and anemia early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,320 people

The number who actually took part.

Started

Jul 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 49 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women visiting a trial facility up to the end of the 28th week of gestation * Women who are planning to remain within the five study districts until at least one-month post-partum OR women whose mothers reside in the selected districts Exclusion Criteria: • Women coming to the trial facility for a non-routine ANC visit (for example, to get a laboratory investigation, to collect a report or her medicine)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia gestational diabetes hypertension, pregnancy-induced pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia Gestational diabetes mellitus (GDM) Pregnancy induced hypertension (PIH)

Contacts and locations

Locations

  • Health posts

    Dhulikhel, Nepal

  • Primary Health Centres

    Siddipet, Telangana, India

  • Primary Health Centres (PHCs)

    Medak, Telangana, India

  • Primary Health Centres (PHCs)

    Rangareddy, Telangana, India

  • Primary Health Centres (PHCs)

    Vikārābād, Telangana, India

  • Primary Health Centres (PHCs)

    Yadadri Bhuvnagiri, Telangana, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.